Tailored cancer therapy put to the test
NCT ID NCT06630325
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a precision medicine approach for people with advanced cancers like breast, ovarian, pancreatic, prostate, or sarcoma. Researchers used genetic and protein tests to track how the cancer changes and then a team of experts recommended personalized drugs. The goal was to see if this approach could guide treatment effectively. The study was stopped early after enrolling 6 participants.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED BREAST CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
OHSU Knight Cancer Institute
Portland, Oregon, 97239, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Fasting during chemo: a new way to boost treatment?
- Can a protein calm the immune System's overreaction to cancer treatment?
- Gut bacteria may fortify bones in breast cancer therapy
- Digital therapy aims to tame the fear that haunts cancer survivors
- Can a pill boost the immune system to fight Hard-to-Treat cancers?
- A remote diet and exercise program aims to help rural cancer survivors shed pounds and lower recurrence risk